Label: WELLMIND VERTIGO- semecarpus anacardium juice, anamirta cocculus seed, conium maculatum flowering top, kerosene, and selenium tablet
- NDC Code(s): 50114-9001-2
- Packager: MediNatura Inc.
- Category: HUMAN PRESCRIPTION DRUG LABEL
- DEA Schedule: None
- Marketing Status: unapproved homeopathic
DISCLAIMER: This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.
Updated May 7, 2015
If you are a consumer or patient please visit this version.
Each 300 mg tablet contains:
Ingredient name Potency Quantity Final dilution
Anacardium orientale 6X 10 mg 7.5X
Cocculus indicus 4X 210 mg 4.15X
Conium maculatum 3X 30 mg 4X
Petroleum 8X 20 mg 9.2X
Selenium metallicum 6X 10 mg 7.5X
Selenium metallicum 12X 10 mg 13.5X
Selenium metallicum 30X 10 mg 31.5XClose
- INDICATIONS & USAGE
WellMindTM Vertigo Tablets are a homeopathic drug product indicated for the treatment of vertigo/dizziness ofvarious origins; mild cognitive impairment (MCI) such as lack of concentration and forgetfulness.Close
- DOSAGE AND ADMINISTRATION
• The dosage schedules listed below can be used as a general guide for the administration of WellMindTM Vertigo Tablets.
• Allow tablets to dissolve completely in the mouth, do not swallow.
Standard Dosage: Adults and children 12 years and older:
3 tablets per day, taking 1 tablet every 4 to 6 hours.
Acute Dosage:Adults and children 12 years and older:
1 tablet every ½ to 1 hour until symptoms lessen, then continue with standard dosage. Do not exceed 12 tablets in 24 hours.Close
• WellMindTM Vertigo Tablets are contraindicated in patients with known hypersensitivity to WellMindTM Vertigo or any of its ingredients.
• Do not use during pregnancy or breastfeeding.Close
- ADVERSE REACTIONS
• No adverse events with a causal relationship to WellMindTM Vertigo tablets have been reported.Close
No negative effects of an overdose have been reported and none are expected due to the homeopathic dilutions.Close
- CLINICAL PHARMACOLOGY
Mechanism of Action
The exact mechanism of WellMindTM Vertigo Tablets is not fully understood.
Not applicable for homeopathic medicinal products.Close
- DOSAGE & ADMINISTRATION
300 mg tablets each containing the active ingredients in the strengths listed under Description.Close
- WellMind Vertigo
- INGREDIENTS AND APPEARANCE
semecarpus anacardium juice, anamirta cocculus seed, conium maculatum flowering top, kerosene, and selenium tablet
Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:50114-9001 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength SEMECARPUS ANACARDIUM JUICE (UNII: Y0F0BU8RDU) (SEMECARPUS ANACARDIUM JUICE - UNII:Y0F0BU8RDU) SEMECARPUS ANACARDIUM JUICE 6 [hp_X] ANAMIRTA COCCULUS SEED (UNII: 810258W28U) (ANAMIRTA COCCULUS SEED - UNII:810258W28U) ANAMIRTA COCCULUS SEED 4 [hp_X] CONIUM MACULATUM FLOWERING TOP (UNII: Q28R5GF371) (CONIUM MACULATUM FLOWERING TOP - UNII:Q28R5GF371) CONIUM MACULATUM FLOWERING TOP 3 [hp_X] PETROLEUM ALKYLATE (UNII: Y61895R84U) (PETROLEUM ALKYLATE - UNII:Y61895R84U) PETROLEUM ALKYLATE 8 [hp_X] SELENIUM (UNII: H6241UJ22B) (SELENIUM - UNII:H6241UJ22B) SELENIUM 6 [hp_X] Inactive Ingredients Ingredient Name Strength LACTOSE (UNII: J2B2A4N98G) MAGNESIUM STEARATE (UNII: 70097M6I30) Product Characteristics Color white Score no score Shape ROUND Size 9mm Flavor Imprint Code Mountain Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:50114-9001-2 1 in 1 CARTON 1 100 in 1 BOTTLE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved homeopathic 01/01/2015 Labeler - MediNatura Inc. (102783016) Establishment Name Address ID/FEI Business Operations MediNatura Inc. 102783016 manufacture(50114-9001)